FDA Inspection
Boothwyn Pharmacy LLCBoothwyn Pharmacy LLC – FDA Inspection, Aug 29, 2023
Record Details
This FDA Inspection record concerns Boothwyn Pharmacy LLC, with an inspection on August 29, 2023, covering drugs.
- Company
- Boothwyn Pharmacy LLC
- Inspection Date
- August 29, 2023
- Product Type
- Drugs
View Company Profile
ID · 4069f48b-7fb3-410d-9435-9653de0e8f3b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1217606
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- FDCA 501(a)(2)(A)Beta-lactam, hazardous, highly potent drugs, prevention of cross-contamination
- FDCA 501(a)(2)(A)Facility design, influx of lesser quality air
- FDCA 501(a)(2)(A)Inadequate smoke studies
- FDCA 501(a)(2)(A)Non-sterile disinfecting agents, ISO 5 area/classified areas
- FDCA 501(a)(2)(A)Sporicidal agent, ISO 5/classified areas
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Boothwyn Pharmacy LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 22, 2024 | Not classified | Philadelphia District Office | Monitoring of Marketed Animal Drugs, Feeds, and Devices |
| June 16, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Boothwyn Pharmacy LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.